Navigation Links
Small Town Company Thrives Against All Odds
Date:8/31/2011

SIERRA MADRE, Calif., Aug. 31, 2011 /PRNewswire/ -- In the quaint little town of Sierra Madre, one budding business just joined the ranks of companies such as Microsoft and Oracle. By helping hospitals all over the country, Wound Care Advantage has reached #316 on Inc. Magazine's "500" list of the nation's fastest-growing companies. The recognition comes despite a volatile healthcare industry and down economy. They were ranked #1,190 just one year ago and are the only wound care company to make the 2011 list. Wound Care Advantage is thriving by helping hospitals keep their doors open to fight the crippling complications of a deadly disease - diabetes.

According to the Centers for Disease Control, diabetes is the seventh leading cause of death. Currently, 60 million Americans are prediabetic. Diabetes and other growing conditions are leading to chronic wounds. Chronic wounds affect more patients than heart attack and stroke victims combined. These non-healing wounds account for $20 billion in healthcare expenditures and over 150,000 amputations every year. Wound care centers around the country are being overwhelmed with this challenge as the recession and an unpredictable industry give them a run for their money.

Wound Care Advantage is helping these medical centers fight back by providing them with financial planning, management, marketing, as well as equipment and training on new wound healing techniques. WCA's hospitals retain some of the highest profit margins in the industry while simultaneously healing patients faster than ever before.

The company's success is in large part due to their emphasis on technology. The company's implementation of hyperbaric oxygen therapy among other techniques has achieved an average healing time of 34 days for wounds that traditionally took months to heal or resulted in amputation. Their Cloud Wound Care technology has cut costs and improved efficiency; it puts everything from electronic medical records to financial statistics at the fingertips of administrators in real time.

The Founder and CEO behind this small town powerhouse is Mike Comer. Comer has rapidly expanded his company with experience, vision, and passion. "Over 50% of patients who receive an amputation die within five years," says Comer. "We founded WCA to heal these wounds before amputations are necessary." The team's passion for partnering with community hospitals and helping patients heal is apparent on the company's website. One webpage boldly displays "Six Rules to Live (or Work) By," which include rules such as "We should earn your business every day" and "We must do well, in order to do good." Wound Care Advantage is doing very well by doing a lot of good for a whole lot of people.

Whether it's their website, technology, or ten-year track record, this small town company is making a big noise by climbing 874 spots in just one year to rank at 316 on the Inc. 500. Comer states, "If you happen to be by our office, drop in at 3:16 - we will be popping champagne."

Wound Care Advantage is a healthcare management company founded in 2002, focused on the development and management of outpatient wound care and hyperbaric oxygen therapies for community hospitals. The company's business is centered on empowering hospitals with their own wound care programs and delivering the best care for patient healing. To learn more about WCA, please visit http://www.thewca.com.

If you'd like more information about this topic, or to schedule an interview with Mike Comer, please call Morgan Craven at 888-484-3922 or send an email to mcraven@thewca.com.

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.


'/>"/>
SOURCE Wound Care Advantage
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Cytokine Demonstrates Oral Efficacy of Small-Molecule MIF Inhibitors
2. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
3. Poniard Pharmaceuticals Announces Updated Results of Picoplatin Phase 2 Trial Demonstrating Survival Benefit in Small Cell Lung Cancer Patients
4. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
5. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
6. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
7. Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference
8. GSK Receives Approval for HYCAMTIN(R) (topotecan) Capsules for the Treatment of Relapsed Small Cell Lung Cancer
9. AngioGenex Files Patent on First Small Molecule Id-Inhibitors for the Treatment of Cancer
10. Pharmion Initiates Pivotal Phase 3 Study of Amrubicin in Small Cell Lung Cancer
11. Study Protocols Will be Amended in Two Small Early-Phase Prasugrel Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... BOSTON , March 27, 2017 ... pharmaceutical company and Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), ... commercialization of innovative therapies based upon tetracycline chemistry, ... sarecycline for the treatment of moderate to severe ... Sarecycline is a once-daily, oral, narrow spectrum tetracycline-derived ...
(Date:3/27/2017)... 2017  Impax Laboratories, Inc. (NASDAQ: IPXL)today announced that ... Bisaro as Impax,s President and Chief Executive Officer ... 27, 2017. Mr. Bisaro will succeed J. Kevin ... Chief Executive Officer since December of 2016. ... experience, Mr. Bisaro, 56, is an accomplished global business ...
(Date:3/27/2017)... March 27, 2017  PhaseRx, Inc. (NASDAQ: PZRX), ... inherited liver diseases in children, today reported financial ... ended December 31, 2016 and provided an update ... continued to make progress during the fourth quarter ... from our non-human primate safety study, and with our ...
Breaking Medicine Technology:
(Date:3/27/2017)... ... March 27, 2017 , ... The ... supply chain professionals, will hold their first Northeast Regional AHVAP Meeting. For 2017, ... , “Increasingly, supply chain and value analysis professionals have a ‘seat at the ...
(Date:3/27/2017)... , ... March 27, 2017 , ... ... Conventional sodium testing methods are complicated and require expert user knowledge. In a ... analytical method dedicated to the simplified, yet highly accurate, determination of sodium. , ...
(Date:3/27/2017)... ... March 27, 2017 , ... From 1999 ... alone responsible for over 33,000 of the 52,404 drug-related deaths in 2015.(2) To ... 1512, which proposes a tax on prescription opioids to fund drug rehabilitation and ...
(Date:3/25/2017)... ... 25, 2017 , ... Getting earned media coverage meaningful for Garden Media Group's ... through the year, Garden Media aims to provide material helpful to clients’ goals and ... pitching client’s key messages to gain coveted media placements, Garden Media wows clients ...
(Date:3/24/2017)... ... March 24, 2017 , ... Mediaplanet today announces distribution of ... current obstacles facing infection prevention and offer strategies for the health care community ... , The print component of “Fighting Infection” is distributed within the Friday, ...
Breaking Medicine News(10 mins):